Humana Inc. (NYSE:HUM) Shares Sold by Maryland State Retirement & Pension System

Maryland State Retirement & Pension System cut its holdings in Humana Inc. (NYSE:HUM) by 6.3% during the fourth quarter, HoldingsChannel reports. The fund owned 6,437 shares of the insurance provider’s stock after selling 435 shares during the period. Maryland State Retirement & Pension System’s holdings in Humana were worth $1,633,000 at the end of the most recent quarter.

A number of other large investors have also recently added to or reduced their stakes in HUM. FPC Investment Advisory Inc. acquired a new position in Humana during the fourth quarter worth $27,000. Centricity Wealth Management LLC acquired a new stake in shares of Humana in the fourth quarter valued at $30,000. LFA Lugano Financial Advisors SA increased its holdings in Humana by 56.3% in the fourth quarter. LFA Lugano Financial Advisors SA now owns 125 shares of the insurance provider’s stock valued at $32,000 after buying an additional 45 shares during the last quarter. OFI Invest Asset Management purchased a new position in Humana in the fourth quarter valued at $33,000. Finally, Atwood & Palmer Inc. increased its holdings in Humana by 64.5% in the fourth quarter. Atwood & Palmer Inc. now owns 153 shares of the insurance provider’s stock valued at $39,000 after buying an additional 60 shares during the last quarter. 92.38% of the stock is currently owned by institutional investors and hedge funds.

Insider Activity

In other news, insider Timothy S. Huval sold 3,703 shares of Humana stock in a transaction that occurred on Tuesday, December 31st. The shares were sold at an average price of $256.26, for a total transaction of $948,930.78. Following the completion of the sale, the insider now directly owns 8,181 shares in the company, valued at approximately $2,096,463.06. This trade represents a 31.16 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Insiders own 0.37% of the company’s stock.

Humana Stock Performance

NYSE HUM opened at $266.33 on Friday. The company has a quick ratio of 1.76, a current ratio of 1.76 and a debt-to-equity ratio of 0.68. The firm has a market cap of $32.14 billion, a P/E ratio of 26.77, a P/E/G ratio of 2.05 and a beta of 0.57. Humana Inc. has a 52-week low of $213.31 and a 52-week high of $406.46. The business’s 50-day moving average price is $271.33 and its 200 day moving average price is $277.52.

Humana (NYSE:HUM) last announced its quarterly earnings data on Tuesday, February 11th. The insurance provider reported ($2.16) EPS for the quarter, beating analysts’ consensus estimates of ($2.26) by $0.10. Humana had a net margin of 1.02% and a return on equity of 11.70%. On average, equities research analysts expect that Humana Inc. will post 16.47 earnings per share for the current year.

Humana Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, April 25th. Stockholders of record on Friday, March 28th will be given a dividend of $0.885 per share. The ex-dividend date of this dividend is Friday, March 28th. This represents a $3.54 dividend on an annualized basis and a dividend yield of 1.33%. Humana’s payout ratio is 35.58%.

Wall Street Analysts Forecast Growth

HUM has been the topic of several recent analyst reports. Morgan Stanley dropped their target price on Humana from $301.00 to $285.00 and set an “equal weight” rating on the stock in a report on Wednesday, February 12th. JPMorgan Chase & Co. dropped their target price on Humana from $257.00 to $256.00 and set a “neutral” rating on the stock in a report on Tuesday, February 18th. Truist Financial increased their target price on Humana from $260.00 to $290.00 and gave the company a “hold” rating in a report on Monday, January 6th. StockNews.com lowered Humana from a “buy” rating to a “hold” rating in a report on Tuesday. Finally, Royal Bank of Canada reaffirmed an “outperform” rating and set a $283.00 price objective on shares of Humana in a report on Wednesday, February 12th. Nineteen equities research analysts have rated the stock with a hold rating and five have assigned a buy rating to the company. Based on data from MarketBeat, Humana has a consensus rating of “Hold” and a consensus target price of $285.68.

Humana Company Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.